Magda is the CEO and founder of intoDNA as well as one of the inventors of STRIDE—the proprietary technology of intoDNA which precisely detects super sensitive DNA damage. Together with her team, she was the overall winner of the BioCity UK DEVELOP acceleration program in June 2018.
Magda has a research background in biophysics, cell biology, DNA damage repair, and CRISPR-Cas biology. She earned her Masters and PhD in cell biophysics at Jagiellonian University in Kraków, Poland and was also a visiting PhD student at UC Davis, Cold Spring Harbor Laboratory, and UMass Medical School in the USA.
Magda’s heart belongs to science and technology, but when not in the lab, you can find her playing the violin and devoting herself to music.